How do I transition from oncologist to primary care after Multiple Myeloma

Transitioning from Oncology to Primary Care After Multiple Myeloma

This is an important question, and it reflects a positive step in your cancer journey. Let me explain what this transition typically involves and what you should know.

Understanding the Transition

According to the NCCN Guidelines for Patients: Multiple Myeloma, even after successful treatment, multiple myeloma often requires ongoing monitoring because the disease can come back (relapse) or progress. This means your transition won't be a complete handoff—instead, it's usually a shared care model where your primary care doctor and oncologist work together.

Key Points About Your Transition

You'll likely need both doctors:

• Your oncology team continues monitoring for myeloma recurrence through regular blood tests (M protein levels, free light chain assays) and imaging
• Your primary care doctor manages your overall health, other medical conditions, and preventive care
• These teams should communicate with each other about your care

Important follow-up tests continue: According to NCCN guidelines, follow-up testing typically includes:

• Blood tests (CBC with differential, metabolic panel, immunoglobulin levels)
• M protein monitoring in blood and urine
• Imaging studies (PET/CT, low-dose CT, or MRI) as recommended
• These help detect if myeloma is returning early

Questions to Ask Your Oncology Team

Before transitioning, have these conversations:

1. "How often do I need to see you for follow-up, and for how long?" (This varies based on your treatment response and risk factors)

2. "What specific tests do I need, and how frequently?" (So your primary care doctor knows what to monitor)

3. "What symptoms should I report to you immediately versus my primary care doctor?" (Red flags like bone pain, infections, or fatigue might indicate relapse)

4. "Will you provide a summary letter to my primary care doctor explaining my diagnosis, treatment, and follow-up plan?" (This is crucial for coordinated care)

5. "Who do I contact if I have questions between appointments?" (Clarify the communication pathway)

6. "Are there any long-term side effects from my treatment I should watch for?" (Some myeloma treatments can affect heart function, kidney function, or increase infection risk)

What Your Primary Care Doctor Should Know

Make sure your primary care physician has:

• Your complete treatment history (drugs used, doses, dates)
• Your baseline lab values and imaging results
• A clear schedule for follow-up oncology visits
• Instructions on which symptoms warrant urgent oncology evaluation
• Information about any ongoing medication side effects

Important Considerations

Bone health: According to NCCN guidelines, bone-building therapy (bisphosphonates or denosumab) is commonly recommended for myeloma patients because the disease weakens bones. Your primary care doctor should know if you're on these medications and monitor your bone health.

Infection risk: Myeloma and its treatments can affect your immune system. Your primary care doctor should be aware of this when evaluating fevers or infections.

Second opinions are normal: As mentioned in the NCCN guidelines, getting a second opinion is a standard part of cancer care. If you're uncertain about your transition plan, it's completely appropriate to ask for clarification from a myeloma specialist.

The Bottom Line

This transition is a sign of progress, but it's not a complete "graduation" from oncology care. Think of it as moving from intensive oncology management to a collaborative model where both your oncologist and primary care doctor play important roles in keeping you healthy.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.